Debates of Nov. 5th, 2018

Question No. 1921

[Navdeep Bains, Liberal, Minister of Innovation]

Mr. Speaker, the Government of Canada did not give a loan to Bombardier in 2016.

Question No. 1925

[Arnold Viersen, Conservative, Peace River—Westlock, AB]

With regard to the working relationship between the CSA Group (formerly the Canadian Standards Association) and the government: (a) is the CSA group an entity of the Canadian Government in any way and, if so, what are the details; (b) since November 4, 2015, has the government or Industry Canada ever authorized the CSA Group to speak on behalf of the government and, if so, who provided the authorization, and what were the parameters of the authorization; and (c) what specific role or authority has the government provided to the CSA Group in the development of (i) laws, (ii) regulations?

[Navdeep Bains, Liberal, Minister of Innovation]

Mr. Speaker, with regard to part (a), the CSA Group is a private business. The CSA Group is not a regulatory entity and does not report to the Minister of Innovation, Science and Economic Development either directly or indirectly through the Standards Council of Canada, SCC. The SCC is a federal Crown corporation whose role includes the coordination of Canada’s voluntary standardization network. The SCC does not have any regulatory authority in its mandate.

The CSA Group is one of 10 standards development organizations, SDOs, accredited by the SCC, which can be found at www.scc.ca/en/accreditation/standards/directory-of-accredited-standards-development-organizations.

The SCC takes its mandate from the Standards Council of Canada Act, its governing legislation, to promote efficient and effective voluntary standardization in Canada, which can be found at http://laws-lois.justice.gc.ca/eng/acts/S-16/index.html. The SCC promotes the participation of Canadians in voluntary standards activities and coordinates and oversees the efforts of the persons and organizations involved in Canada’s standardization network.

With regard to part (b), neither the SCC nor the CSA Group is a regulatory entity. The SCC is not aware of any authorization given to the CSA Group to speak on behalf of the government.

With regard to part (c), neither the SCC nor the CSA Group is a regulatory entity. The SCC is not aware of any role or authority given to the CSA Group in the development of (i) laws or (ii) regulations.

Questions Passed as Orders for Returns

[Kevin Lamoureux, Liberal, Parliamentary Secretary to the Leader of the Government in the House of Commons]

Furthermore, Mr. Speaker, if revised responses to Question No. 1532, originally tabled on April 16, 2018, and Question No. 1680, originally tabled on June 8, 2018, and the government's responses to Questions Nos. 1882 to 1884, 1888, 1890 to 1903, 1905 to 1907, 1909 to 1912, 1915, 1916, 1918, 1920, 1922 to 1924, 1926 and 1927 could be made orders for return, these returns would be tabled immediately.

[The Speaker, Liberal, Geoff Regan]

Is that agreed?

[Some hon. members]

Agreed.

Question No. 1532

[Tom Kmiec, Conservative, Calgary Shepard, AB]

With regard to immigration to Canada, between December 7, 2016, and December 6, 2017: (a) how many economic class immigrants have been admitted to Canada; (b) how many family class immigrants have been admitted to Canada; (c) how many refugees have been admitted to Canada; (d) how many temporary student visas were issued and how many individuals were admitted to Canada on a temporary student visa; (e) how many temporary worker permits were issued and how many individuals were admitted to Canada on a temporary worker permit; (f) how many temporary visitor records were issued and how many individuals were admitted to Canada on a temporary visitor record; (g) how many temporary resident permits were issued; (h) how many temporary resident permits were approved by the Minister of Immigration, Refugees and Citizenship; (i) for (a) to (h), what is the breakdown by source country by each class of migrant; and (j) for applications for the categories enumerated in (a) to (h), how many individuals were found inadmissible under the Immigration and Refugee Protection Act in (i) section 34, (ii) section 35, (iii) section 36, (iv) section 37, (v) section 40?

(Return tabled)

Question No. 1680

[Mark Warawa, Conservative, Langley—Aldergrove, BC]

With regard to immigration to Canada between December 7, 2016, to December 6, 2017: (a) how many economic class immigrants have been admitted to Canada; (b) how many family class immigrants have been admitted to Canada; (c) how many refugees have been admitted to Canada; (d) how many temporary student visas were issued and how many individuals were admitted to Canada on a temporary student visa; (e) how many temporary worker permits were issued and how many individuals were admitted to Canada on a temporary worker permit; (f) how many temporary visitor records were issued and how many individuals were admitted to Canada on a temporary visitor record; (g) how many temporary resident permits were issued; (h) how many temporary resident permits were approved by the Minister of Immigration, Refugees and Citizenship; (i) for (a) to (h), what is the breakdown by source country by each class of migrant; (j) for applications for the categories enumerated in (a) to (h), how many individuals were found inadmissible, divided by each subsection of section 34 of the Immigration and Refugee Protection Act; (k) for applications for the categories enumerated in (a) to (h), how many individuals were found inadmissible, divided by each subsection of section 35 of the Immigration and Refugee Protection Act; (l) for applications for the categories enumerated in (a) to (h), how many individuals were found inadmissible, divided by each subsection of section 36 of the Immigration and Refugee Protection Act; (m) for applications for the categories enumerated in (a) to (h), how many individuals were found inadmissible, divided by each subsection of section 37 of the Immigration and Refugee Protection Act; and (n) for application for the categories enumerated in (a) to (h), how many individuals were found inadmissible, divided by each subsection of section 40 of the Immigration and Refugee Protection Act?

(Return tabled)

Question No. 1882

[Gord Johns, NDP, Courtenay—Alberni, BC]

With regard to the New Veterans Charter and the Pension for Life, what is: (a) the number of veterans who applied for and were granted the incapacity allowance under the New Veterans Charter and Pension for Life, from 2008 to 2018, broken down by (i) amount, (ii) year, (iii) gender; (b) the number of veterans who applied for the incapacity allowance but were denied under the New Veterans Charter and Pension for Life, from 2008 to 2018, broken down by (i) amount, (ii) year, (iii) gender; (c) the number of veterans who applied for and were granted the additional monthly supplement of the incapacity allowance under the New Veterans Charter and Pension for Life, from 2008 to 2018, broken down by (i) amount, (ii) year, (iii) gender; (d) the number of veterans who applied for the additional monthly supplement of the incapacity allowance but were denied under the New Veterans Charter and Pension for Life, from 2008 to 2018, broken down by (i) amount, (ii) year, (iii) gender; (e) the number of veterans who applied for and were granted the disability award lump sum under the New Veterans Charter and Pension for Life, from 2008 to 2018, broken down by (i) amount, (ii) year, (iii) gender; (f) the number of veterans who applied for the disability award lump sum but were denied under the New Veterans Charter and Pension for Life, from 2008 to 2018, broken down by (i) amount, (ii) year, (iii) gender; (g) the number of veterans who applied for and were granted the disability award monthly pay-out option under the New Veterans Charter and Pension for Life, from 2008 to 2018, broken down by (i) amount, (ii) year, (iii) gender; and (h) the number of veterans who applied for the disability award monthly pay-out option but were denied under the New Veterans Charter and Pension for Life, from 2008 to 2018, broken down by (i) amount, (ii) year, (iii) gender?

(Return tabled)

Question No. 1883

[Alex Nuttall, Conservative, Barrie—Springwater—Oro-Medonte, ON]

With regard to contracts and expenditures with Green Leaf Distribution, since January 1, 2016, and broken down by department, agency, Crown corporation or other government entity: what are the details of each contracts and expenditures, including (i) date, (ii) amount, (iii) description of goods or services provided, (iv) file numbers, (v) original contract value, (vi) final contract value, if different than the original value?

(Return tabled)

Question No. 1884

[Cheryl Gallant, Conservative, Renfrew—Nipissing—Pembroke, ON]

With regard to Operation HONOUR, since July 23, 2015: what is the number of sexual assaults involving rape reported and, of those cases, what is (i) the number of times the suspect was removed from the unit while the complaint was under investigation, (ii) the number of times the suspect was removed from the unit once charged, (iii) the number of times the complainants were removed from the unit, (iv) the number of times the complainants were reassigned duties, (v) in cases where charges were filed, the length of time per case from reporting the incident to the time the accused was charged, for each case, (vi) the number of times padres, officiate or chaplain reported cases of rapes confided in them by complainants to the chain of command, (vii) the number of times rape complainants, who called the Op HONOUR line, were asked for their names, (viii) the number of times complainants were told once they sign on to the military the member has ‘unlimited liability’ to the Canadian Armed Forces (CAF), (ix) the number of people charged, (x) the number of people who admitted guilt to the sexual assault involving raping another member of the CAF, (xi) the number of charges that have been prosecuted, (xii) the length of time between the date of charge and the date of the hearing, trial or court martial, for each case, (xiii) the number of convictions rendered, (xiv) the total length of time between a report of incident to sentencing, for each case, (xv) the number of times convicted members were discharged from the military?

(Return tabled)

Question No. 1888

[Don Davies, NDP, Vancouver Kingsway, BC]

With regard to the Advisory Council on the Implementation of National Pharmacare (Advisory Council): (a) who will be the members of the Advisory Council, broken down by (i) nomination date, (ii) complete name, (iii) total remuneration, (iv) length of mandate; (b) on what date exactly does the government anticipate appointing the last of the initial members of the Advisory Council; (c) what are the timelines and important dates for the Advisory Council’s consultations; (d) will the Advisory Council’s consultations be held in public; (e) who will be consulted by the Advisory Council, broken down by (i) organizations or individuals already consulted, (ii) organizations or individuals to be consulted, (iii) dates of all previous and planned consultations, (iv) length of consultation period; (f) on what date exactly is the Advisory Council planning to table its interim and final reports; and (g) how will financial and human resources be allocated with respect to the Advisory Council, broken down by (i) types of expenses, (ii) allocated sums?

(Return tabled)

Question No. 1890

[Nathan Cullen, NDP, Skeena—Bulkley Valley, BC]

With regard to the impending purchase of the Trans Mountain pipeline by the government, can the Minister of Natural Resources confirm in relation to the Pipeline Safety Act and National Energy Board Act: (a) whether the government considers itself a company as authorized under these acts to operate a pipeline; and (b) if the answer to (a) is affirmative, how this pertains to the National Energy Board’s mandate under these acts to order a company to reimburse the costs incurred by any government institution due to the unintended or uncontrolled release of oil, gas or any other commodity from a pipeline?

(Return tabled)

Question No. 1891

[Nathan Cullen, NDP, Skeena—Bulkley Valley, BC]

With regard to consultations undertaken by Kinder Morgan with Indigenous groups impacted by the Trans Mountain pipeline expansion and given the impending purchase of the pipeline by the government, will the Minister of Natural Resources: (a) table all mutual benefit agreements previously reached between Kinder Morgan and First Nation band councils given that they will soon constitute agreements reached with the Crown; and (b) guarantee that all such agreements established the free, prior and informed consent to the pipeline from each band?

(Return tabled)

Question No. 1892

[Ruth Ellen Brosseau, NDP, Berthier—Maskinongé, QC]

With regard to federal spending in the riding of Berthier—Maskinongé, for each fiscal year since 2014, inclusively: what are the details of all grants and contributions and all loans to every organization, group, business or municipality, broken down by the (i) name of the recipient, (ii) municipality of the recipient, (iii) date on which the funding was received, (iv) amount received, (v) department or agency that provided the funding, (vi) program under which the grant, contribution or loan was made, (vii) nature or purpose?

(Return tabled)

Question No. 1893

[Linda Duncan, NDP, Edmonton Strathcona, AB]

With regard to Health Canada’s notice of a recall for a list of Valsartan products supplied by Chinese corporation Zhejiang Huahai Pharmaceuticals: (a) on what date did Health Canada become aware of the contamination of these drugs with N-nitrosodimethylamine (NDMA); (b) was the recall issued at the request of Canadian authorities; (c) what is deemed a long-term exposure to this carcinogen; (d) if there was a delay in issuing the recall after Health Canada was informed of the contamination, what were the reasons for the delay in the public notice; (e) how was Health Canada made aware of the contamination of the valsartan medicines; (f) did Health Canada directly conduct any laboratory tests on these drugs to determine their safety before approving their use in Canada; (g) has Health Canada or any federal authority undertaken any investigations of the laboratory and manufacturing facilities of Zhejiang Huahai Pharmaceuticals; (h) why did Health Canada advise patients to continue taking the Valsartan products despite the knowledge it was contaminated with a carcinogen and who made that decision; (i) are any other products manufactured by Zhejiang Huahai Pharmaceuticals currently being distributed, sold or prescribed in Canada; (j) what actions has Health Canada taken to test alternative blood pressure medicines being prescribed in Canada to determine their safety; and (k) what information has been provided to Health Canada on adverse effects reported by Canadians taking Valsartan?